Chromophobe renal cell carcinoma

Get in touch with RARE Concierge.

Contact RARE Concierge

Chromophobe renal cell carcinoma

Synonyms: Chromophobe renal cell adenocarcinoma

Chromophobe renal cell carcinoma is a rare subtype of renal cell carcinoma originating from the intercalating cells of the collecting ducts and macroscopically manifesting as a well-circumscribed highly lobulated solid tumor that is usually diagnosed at an early stage. It is frequently asymptomatic or may present with nonspecific symptoms such as weight loss fever or fatigue. The classic presentation observed in renal tumors (hematuria flank pain and palpable mass) is occasionally observed and usually indicates an advanced stage of the disease. It is most frequently sporadic however several familial cases associated with Birt-Hogg Dubé syndrome have been described.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: // Data version October 2023.

Newly diagnosed with
Chromophobe renal cell carcinoma?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

My Faulty Gene

My Faulty Gene is a nonprofit organization which provides information and assistance to any individual whose family medical history suggests genetic testing might be helpful in identifying an increased risk of disease due to a genetic mutation. We believe that everyone in need of genetic testing should have access to it.

My Little Sunshine Foundation

My Little Sunshine is a non-profit foundation dedicated to educating people about the importance of fertility preservation and making fertility resources accessible to all.


Educate and provide resources to POC with Rare Cancers

Clinical Trials

For a list of clinical trials in this disease area, please click here.